06 Identity & adulteration

How we prove a vitamin D3 lot is cholecalciferol

Technical document 06 · Reviewed 2026-11-18 · Vitamin D3

On this page
  1. The four layers of identity
  2. What the HPLC has to show
  3. The IU-to-microgram ratio
  4. D3 versus D2 in the same assay
  5. The carrier is part of the identity
  6. Why XRD does not identify the powder
  7. The routes that pass a headline assay
  8. How to write the identity specification
  9. Five questions for the supplier

A vitamin D3 lot is identified in four layers: the documents and the lot chain, the chromatographic identity, the ultraviolet spectrum, and the carrier with its mass balance. At 100,000 IU/g the cholecalciferol is 0.25% of the powder, so appearance and a headline assay cannot carry the identification.

In one line

At 0.25% cholecalciferol the powder is mostly carrier, so identity has to come from the chromatogram and the mass balance, not from the colour.

The four layers of identity

What each identity layer proves, and what it does not
LayerEvidenceWhat it provesWhat it does not prove
DocumentaryName, CAS 67-97-0, formula C27H44O, COA, lot code, specificationThe lot in the pack is the lot in the fileThat the chemistry matches the file
ChromatographicRetention time against a cholecalciferol standard, co-injection, peak purityThe main peak is cholecalciferolThe carrier or the concentration
SpectroscopicUV spectrum around 265 nm, diode-array comparisonThe peak has the vitamin D chromophoreWhich vitamin D, if the method does not resolve D2
MatrixCarrier declaration, IU/g versus µg/g, loss on drying, mass balanceThe powder is the grade that was orderedThe identity of the molecule on its own

A certificate can be genuine and still describe a different lot; a chromatogram can hide ergocalciferol if the method does not resolve it; a correct peak can sit in a powder whose carrier is undeclared. Identity is the four layers agreeing.

What the HPLC has to show

Cholecalciferol is normally determined by HPLC with UV detection near 265 nm against an external reference standard. The retention time establishes the peak, and a standard addition strengthens the assignment. The method has to resolve cholecalciferol from ergocalciferol and the other vitamin D isomers.

Ask for the chromatogram, column, mobile phase, wavelength and integration parameters. The chromatogram should show the cholecalciferol peak, the region where ergocalciferol would appear, and the reference standard run under the same conditions. The IU/g figure is calculated from the mass result at 40 IU per microgram, so the calibration is part of the identity evidence.

LC-MS helps when the peak assignment is disputed: cholecalciferol and ergocalciferol differ in molecular mass, 384.64 and 396.65 g/mol, so a mass detector separates them even when the UV peaks overlap.

The IU-to-microgram ratio

The potency on the label and the mass on the certificate are connected by a fixed ratio: 1 µg of cholecalciferol is 40 IU, so 100,000 IU/g is 2,500 µg/g, and the vitamin is 0.25% of the powder by weight. A certificate that reports one unit without the other is only half readable.

The ratio is also the arithmetic check on a suspicious result. A figure of 2,500 µg/g read as IU would suggest a powder at one fortieth of the declared grade, while 2,500 IU/g is an actual under-concentration. Converting both ways keeps a unit error from being mistaken for a quality failure.

D3 versus D2 in the same assay

A method calibrated only with a cholecalciferol standard can misreport an ergocalciferol peak, because the two have similar but not identical UV response. The certificate should name the standard and state the detection limit for the D2 screen.

Both forms are permitted vitamin D sources in the EU, the US and the UK, so D2 is not automatically a legal problem. It is a specification problem: a label that names D3 cannot be satisfied by D2.

The carrier is part of the identity

At 100,000 IU/g, one gram contains 2,500 µg of cholecalciferol and about 997.5 mg of carrier and spray-drying solids. The mass balance should close: assay, loss on drying and carrier add up to the powder, and the carrier share has to be declared.

The carrier also interferes with identity testing. Microscopy sees starch granules or gum particles, not the molecule; an infrared spectrum sees the matrix as well as the vitamin. The specification must name the carrier so that a change of carrier is a change of product, and loss on drying at or below 5.0% and at least 95% through 40 mesh describe that matrix, not the vitamin.

Why XRD does not identify the powder

Cholecalciferol is crystalline as an isolated substance, but the 100,000 IU/g product is a spray-dried dispersion in which the vitamin is 0.25% of the mass. XRD sees the carrier and the spray-dried matrix, not a cholecalciferol lattice: the organic crystals would sit far below the few-percent detection limit of a phase scan, and the carrier may return only a halo. The method cannot distinguish cholecalciferol from ergocalciferol at this loading, and it cannot quantify IU.

XRD is therefore not a release identity test here. What is used is HPLC with ultraviolet detection near 265 nm, retention time against a cholecalciferol standard, a diode-array spectrum, a D2 screen and the mass balance. A diffraction pattern may help with the crystalline raw material, but it is not evidence about the drum.

The routes that pass a headline assay

Routes that survive a total assay, and the test that catches each
RouteWhat still passesWhat catches it
Under-concentrationAppearance and a nominal grade nameHPLC result against 100,000 IU/g, mass balance
Ergocalciferol substituted or addedA broad “vitamin D” assayRetention time, D2 standard, UV or mass detection
Undeclared carrier or extra diluentIU/g inside the rangeCarrier declaration, mass balance, LOD
Oxidised or aged materialA result near the floorChromatogram impurity profile, appearance, stability history

Each route satisfies the number that is easiest to check, so the defence is to specify the headline number and the supporting evidence together: identity by retention time, the D2 screen, the carrier, the mass balance and the lot traceability.

How to write the identity specification

Write the full name and the form: “Cholecalciferol (colecalciferol, CAS 67-97-0), 100,000 IU/g spray-dried powder on a declared carrier.” Then the analytical lines: “Identification by HPLC retention time against a cholecalciferol reference standard; vitamin D3 ≥100,000 IU/g; equivalent 2,500 µg/g; carrier starch, gum arabic or maltodextrin, named on the certificate; loss on drying ≤5.0%; ≥95% through 40 mesh; heavy metals and microbiology as listed.”

Add the negative statement: “No ergocalciferol added; no undeclared carrier.” Pair it with the D2 screen and the mass balance, since a negative statement is only useful if the method can detect the substance. State whether the IU result is on an as-sold or dried basis, and require the chromatogram near the floor.

Five questions for the supplier

  1. Which IU/g and µg/g results belong to this lot, and on what basis?
  2. Can you send the chromatogram, the column, the mobile phase and the wavelength?
  3. Was ergocalciferol screened, with what standard and what detection limit?
  4. What is the carrier, at what proportion, and is it the only diluent?
  5. Does the certificate name the lot, the manufacturing site and the specification version?

Five direct answers amount to an identity file. The product page carries the catalog specification; the COA page explains each figure; the grade page explains the concentration; the D3 versus D2 page covers the molecular difference. The HPLC method note explains the separation, and the quality page describes the release workflow.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation